U.S. Markets open in 16 hrs, 23 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 10:53 AM EDT | 63.25 | |
|---|---|---|
| Day High 09:32 AM EDT | 64.80 |
|
| Range | 1.55 | |
| Volume | 228,770 | |
| 30-Day Avg. Vol. | 282,000 |
|
| Difference | -18.88% | |
| Market Cap. | 33.43 B | |
| Change | -1.32 B | |
| Shares Out. | 513.65 M | |
| Percent Traded | 0.04% | |
| Revenue | 7.74 B | |
| Earnings | 1.57 B | |
| EPS (TTM) | 2.74827 |
| 52-Wk Low 8/16/07 | 50.255 | |
|---|---|---|
| 52-Wk High 4/8/08 | 73.73 |
|
| Range | 23.48 | |
| Prev. Close 7/2/08 | 66.02 | |
| Today's Open | 64.66 | |
| Change | -2.06% | |
| Dividend (TTM) | 0.94232 | |
| Div. Yield (TTM) | 1.48% |
|
| Beta | 0.4684 | |
| P/E Ratio (TTM) | 25.81 | |
| P/E Ratio (Fwd.) | — |
Novo Nordisk can tell diabetics where to stick it. One of the world's leading producers of insulin, Novo Nordisk also makes insulin analogues, injection devices, and diabetes education materials. Its products ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — 12/31/07 | 0.325 12/31/07 |
—
—
|
| Last Quarter | — 3/31/08 | 0.70 3/31/08 |
—
—
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 2.18 B | 7.75 B |
| Gross Profit | 1.68 B | 7.08 B |
| Operating Income | 561.71 M | 1.85 B |
| Net Income | 446.75 M | 1.58 B |
